Our client’s journeys often start from investing in medical device R&D and related start-ups in the UK
we bring a suite of expertise that reaches much deeper into the pharmaceutical industry. Our experiences allow us to carefully navigate the legal landscape of the industry, as well as secure key partnerships and permissions for our client’s that are critical in their business pipeline. We have recently just assisted a major China-listed company in a collaboration with a Swiss corporation regarding their latest antibiotic medicine’s marketing rights in China.
Medicines discovery support (biosciences, NGS, radiolabel, and lab chemistry) is another area where we have accumulated considerable experiences in, specifically regarding asset acquisitions, management integration, import & export, and IP disputes. As Chinese companies are dominant in the pharmaceutical industry, we often act as their UK legal advisors in assisting on their domestic UK matters.
In a highly regulated industry, we assist our clients in navigating the complex regulatory framework in the UK and EU. We are often involved in marketing authorisation applications with MHRA and EMA. In specialist M&A deals, we work in parallel with industry experts to understand specific regulatory implications to ensure that we bring the most value to our clients.